Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 7/7/2020
SIETES contiene 93061 citas

 
 
<< anterior 21 a 40 de 144 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Abou-Alfa GK, Johnson P, Knox JJ, Capanu M, Davidenko I, Lacava J, Leung T, Gansukh B, Saltz LB. Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma. A randomized trial. JAMA 2010;304:2154-60. [Ref.ID 89666]
22. Cita con resumen
Youngster I, Arcavi L, Schechmaster R, Akayzen Y, Popliski H, Shimonov J, Beig S, Berkovitch M. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review. Drug Saf 2010;33:713-26. [Ref.ID 89267]
23. Cita con resumen
van der Pal HJH, van Dalen EC, Hauptmann M, Kok WE, Caron HN, van den Bos C, Oldenburger F, Koning CCE, van Leeuwen FE, Kremer LCM. Cardiac function in 5-year survivors of childhood cancer. A long-term follow-up study. Arch Intern Med 2010;170:1247-55. [Ref.ID 88933]
24.Tiene citas relacionadas Cita con resumen
Gianni L, Eiermann W, Semiglazov V, Manikhas A, Lluch A, Tjulandin S, Zambetti M, Vazquez F, Byakhow M, Lichinitser M, Climent MA, Ciruelos E, Ojeda B, Mansutti M, Bozhok A, Baronio R, Feyereislova A, Barton C, Valagussa P, Baselga J. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort. Lancet 2010;375:377-84. [Ref.ID 87805]
25.Tiene citas relacionadas
Seal MD, Chia SK. Challenging the dogma on trastuzumab: a matter of the heart. Lancet 2010;375:349-50. [Ref.ID 87799]
26.Tiene citas relacionadas
Sipkins DA. Rendering the leukemia cell susceptible to attack. N Engl J Med 2009;361:1307-9. [Ref.ID 86823]
27.Tiene citas relacionadas
Dombret H, Gardin C. An old AML drug revisited. N Engl J Med 2009;361:1301-3. [Ref.ID 86822]
28.Tiene citas relacionadas
Fernández HF, Sun Z, Yao X, Litzow MR, Luger SM, Paietta EM, Racevskis J, Dewald GW, Ketterling RP, Bennett JM, Rowe JM, Lazarus HM, Tallman MS. Anthracycline dose intensification in acute myeloid leukemia. N Engl J Med 2009;361:1249-59. [Ref.ID 86819]
29.Tiene citas relacionadas
Löwenberg B, Ossenkoppele GJ, van Putten W, Schouten HC, Graux C, Ferrant A, Sonneveld P, Maertens J, Jongen-Lavrencic M, von Lilienfeld-Toal M, Biemond BJ, Vellenga E, van Marwijk Kooy M, Verdonck LF, Beck J, Döhner H, Gratwohl A, Pabst T, Verhoef G, for the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) German AML Study Group (AMLSG) and Swiss Group for Clinical Cancer Research (SAKK) Collaborative Group. High-dose daunorubicin in older patients with acute myeloid leukemia. N Engl J Med 2009;361:1235-48. [Ref.ID 86818]
30. Cita con resumen
Pérez C, Agustí M!A, Tornos P. Cardiotoxicidad tardía inducida por antraciclinas. Med Clin (Barc) 2009;133:311-3. [Ref.ID 86739]
31.Tiene citas relacionadas Cita con resumen
Anónimo. Ixabépilone. Très proche des taxanes, sans faire mieux. Prescrire 2009;29:249-52. [Ref.ID 85586]
33.Tiene citas relacionadas
Sparano JA. Weekly paclitaxel in the adjuvant treatment of breast cancer. The author replies. N Engl J Med 2008;359:310-1. [Ref.ID 83544]
34.Tiene citas relacionadas
Aksoy S, Dizdar O, Altundag K. Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 2008;359:310. [Ref.ID 83543]
35.Tiene citas relacionadas
Kami M. Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 2008;359:310. [Ref.ID 83542]
36. Cita con resumen
Heemstra HE, de Vrueh RL, van Weely S, Büller HA, Leufkens HGM. Predictors of orphan drug approval in the European Union. Eur J Clin Pharmacol 2008;64:545-52. [Ref.ID 82991]
37.Tiene citas relacionadas Cita con resumen
Sparano JA, Wang M, Martino S, Jones V, Pérez EA, Saphner T, Wolff AC, Sledge Jr GW, Wood WC, Davidson NE. Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 2008;358:1663-71. [Ref.ID 82660]
38.Tiene citas relacionadas
Moore A. Breast-cancer therapy - looking back to the future. N Engl J Med 2007;357:1547-9. [Ref.ID 81218]
39.Tiene citas relacionadas Cita con resumen
Hayes DF, Thor AD, Dressler LG, Weaver D, Edgerton S, Cowan D, Broadwater G, Goldstein LJ, Martino S, Ingle JN, Henderson IC, Norton L, Winer EP, Hudis CA, Ellis MJ, Berry DA, for the Cancer and Leukemia Group B (CALGB) Investigators. HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med 2007;357:1496-506. [Ref.ID 81214]
40. Cita con resumen
Murphy CA, Dargie HJ. Drug-induced cardiovascular disorders. Drug Saf 2007;30:783-804. [Ref.ID 81131]
Seleccionar todas
 
<< anterior 21 a 40 de 144 siguiente >>